Explore the shift in U.S. antitrust policy to settle cases with PBMs, impacting drug pricing, transparency, and healthcare costs for consumers.

Explore how CMS is regulating Pharmacy Benefit Managers under CAA 2026, seeking feedback on compensation models and data reporting requirements. Act by July 20, 2026!

Explore key Medicare Part D reforms targeting pharmacy benefit managers to enhance transparency and compliance. Engage in shaping vital regulatory changes.

Learn how the HELP Copays Act ensures copay assistance counts towards patient costs, protecting access to medications and financial stability.

Discover how PBM ownership by insurers influences Medicare drug costs and understand the implications for pharmacies and patient access.

President Trump's initiative to regulate insurers and PBMs aims to reduce drug prices and ensure savings benefit patients. Discover the impact on healthcare costs.

Senate hearing highlights rising healthcare costs, Medicaid spending, and the need for reform in telehealth and pharmacy management. Learn about budget impacts.

Explore significant regulatory changes affecting workers' compensation and pharmacy benefit managers. Stay informed on compliance and market dynamics.

Explore the impact of Pharmacy Benefit Managers on insurance premiums and drug pricing, and the regulatory insights from Abby Alpert's recent study.

Pennsylvania lawmakers propose enhanced oversight on PBMs to ensure fair reimbursement and access to medication, addressing the crisis in local pharmacies.